Blood Thinners: Are You Getting the Right Dose?
Some people taking blood-thinning medications might be getting the wrong dose, according to a new study.
The Burden of AFib in Women
Atrial fibrillation (AFib) may not affect women and men in the same way, a new study found.
The Antidote for Blood Thinners
Bleeding can be a major concern for patients taking blood thinners. But what if the effects of these drugs could be safely reversed in an emergency situation?
Understanding Atrial Fibrillation
"AFib" may sound like a little white lie, but it’s actually a serious medical condition. Atrial fibrillation, or AFib, is the most common type of heartbeat rhythm problem.
So You've Got Atrial Fibrillation — What's Next?
Atrial fibrillation (AFib) is the most common cause of irregular heartbeat, affecting nearly 2.7 million Americans. If left untreated, it can significantly increase the risk of stroke and other heart problems. But what does an AFib diagnosis really mean?
How to Choose an Anticoagulant
If you need to take an anticoagulant — popularly known as a blood thinner — you don’t want it to cause bleeding, but some might raise your bleeding risk.
Celexa and Risk of Arrhythmia
The U.S. Food and Drug Administration (FDA) is clarifying dosing and warning recommendations for the antidepressant Celexa ( citalopram hydrobromide ; also available in generic form).
FDA Drug Safety Communication: Pradaxa
The U.S. Food and Drug Administration (FDA) is alerting the public to important storage and handling requirements for Pradaxa ( dabigatran etexilate mesylate ) capsules.
(UPDATE 12/19) FDA Drug Safety Communication: Multaq (dronedarone)
The U.S. Food and Drug Administration (FDA) is reviewing data from a clinical trial that was evaluating the effects of the antiarrhythmic drug Multaq ( dronedarone ) in patients with permanent atrial fibrillation.
Heart disease costs are predicted to triple in the next 20 years in the U.S., according to predictions from the American Heart Association (AHA).